Details of Disease

Disease Name

Gastric motility disorder

Disease Class

DA21: Oesophagus motility disorder

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISXTE5N: Gastric motility disorder

ICD-11

ICD-11: DA21

ICD-10

ICD-10: K22.4

General Information of Disease (ID: DISXTE5N)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 3 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
AG-TMB711	DMEKMY9	Approved	NA	[1]
Cimetropium bromide	DMZHPNE	Approved	Small molecular drug	[1]
Otilonium bromide	DM05968	Approved	Small molecular drug	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 6 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
E-3620	DMWF95G	Discontinued in Phase 2	NA	[2]
KC-11458	DMOITN2	Discontinued in Phase 2	NA	[3]
SK-896	DM8NCUZ	Discontinued in Phase 2	NA	[4]
SLV-305	DMBZM0D	Discontinued in Phase 2	NA	[5]
SLV-323	DMHRYX6	Discontinued in Phase 1	NA	[6]
SC-53116	DM2O8SF	Terminated	Small molecular drug	[7]
------------------------------------------------------------------------------------


⏷ Show the Full List of 6 Drug(s)

This Disease is Treated as An Indication in 4 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
AS-9705	DMR01O4	Investigative	Small molecular drug	[6]
CEM-301	DMQ0HCT	Investigative	NA	[8]
GSK-894281	DMSOWPE	Investigative	Small molecular drug	[9]
RQ-00000010	DMLN280	Investigative	NA	[10]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004004)
3	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008138)
4	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003118)
5	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014470)
6	Emerging drugs for chemotherapy-induced emesis. Expert Opin Emerg Drugs. 2006 Mar;11(1):137-51.
7	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 238).
8	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 297).
9	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 246).
10	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 9).